Royalty Pharma Plc (RPRX)
64.76
+0.90
(+1.41%)
USD |
NASDAQ |
Oct 26, 16:00
64.88
+0.12
(+0.19%)
After-Hours: 19:16
Royalty Pharma EPS Diluted (Quarterly) : 0.04 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.04 |
| March 31, 2026 | 0.6738 |
| December 31, 2025 | 0.4992 |
| September 30, 2025 | 0.6654 |
| June 30, 2025 | 0.0745 |
| March 31, 2025 | 0.414 |
| December 31, 2024 | 0.4673 |
| September 30, 2024 | 1.214 |
| June 30, 2024 | 0.226 |
| March 31, 2024 | 0.0106 |
| December 31, 2023 | 1.106 |
| September 30, 2023 | 0.16 |
| June 30, 2023 | 0.5045 |
| March 31, 2023 | 0.7647 |
| December 31, 2022 | -1.029 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.3247 |
| June 30, 2022 | 0.6979 |
| March 31, 2022 | 0.1193 |
| December 31, 2021 | 0.0185 |
| September 30, 2021 | 0.238 |
| June 30, 2021 | 1.077 |
| March 31, 2021 | 0.1773 |
| December 31, 2020 | 0.4406 |
| September 30, 2020 | 0.7855 |
| June 30, 2020 | 1.208 |
| March 31, 2020 | 0.1947 |
| December 31, 2019 | 3.882 |
| September 30, 2019 | 1.118 |
| June 30, 2019 | 0.4146 |
| March 31, 2019 | 1.004 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -0.5405 |
| Johnson & Johnson | 0.0858 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 81.49M |
| Revenue (Quarterly) | 674.14M |
| Total Expenses (Quarterly) | 656.26M |
| Enterprise Value | 39.54B |
| Gross Profit Margin (Quarterly) | 99.81% |
| Profit Margin (Quarterly) | 12.09% |
| Earnings Yield | 2.90% |
| Operating Earnings Yield | 4.64% |
| Normalized Earnings Yield | 2.727 |